US Partial Clinical Hold on Diamyd Phase III Trial Lifted by the FDA

STOCKHOLM, Nov. 28, 2022. Diamyd Medical announced today that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on the confirmatory Phase III trial DIAGNODE-3, evaluating the safety and efficacy of the precision...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials